Quince Therapeutics, Inc. Financial Ratios — QNCX Stock

Profitability (USD)

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-30.96	-37.5	-48.97	-55.75	-43.57	-23.09	-40.25	-80.75
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	7	- -	- -	- -	1	- -	14	15	18
ST Debt	- -	- -	- -	- -	1	- -	- -	- -	18
LT Debt	7	- -	- -	- -	- -	- -	14	15	- -
Total Debt/EBITDA	-0.69	- -	- -	-0.01	-0.01	-0.01	-0.52	-0.41	-0.37
Net Debt/EBITDA	0.02	2.06	1.31	0.85	0.77	0.87	0.27	-0.23	-0.24
Total Debt/EBIT	-0.69	- -	- -	-0.01	-0.01	-0.01	-0.51	-0.41	-0.37
Net Debt/EBIT	0.02	2.05	1.31	0.85	0.77	0.87	0.27	-0.22	-0.24
EBITDA to Interest Expense	-6.28	-12.61	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-6.33	-12.83	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	-6.31	-12.66	- -	- -	- -	- -	- -	- -	- -
Interest Expense	2	1	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-263.62	-45.04	-56.11	-77.39	-177.57	-277.38	-190.35	-328.82	-492.28
Long-Term Debt/Equity (%)	- -	- -	- -	0.12	0.35	- -	16.16	48.81	- -
Long-Term Debt/Capital (%)	-54.43	- -	- -	-0.14	-0.18	- -	-4.5	-4.07	-0.07
Long-Term Debt/Total Assets (%)	92.91	- -	- -	0.11	0.32	- -	8.19	12.85	0.35
Total Debt/Equity (%)	-35.36	- -	- -	0.26	0.98	0.45	16.24	49.13	-51.72
Total Debt/Capital (%)	-54.43	- -	- -	-0.31	-0.49	-0.16	-4.52	-4.1	-4.18
Total Debt/Total Assets (%)	92.91	- -	- -	0.24	0.87	0.44	8.23	12.94	19.75
Net Debt to Equity	0.85	76.23	-44.35	-38.8	-58.8	-44.32	-8.61	26.9	-34.21
Net Debt/Capital (%)	0.84	43.11	42.33	31.38	22.85	13.41	2.24	-2.2	-2.73
EBITDA	-10	-12	-39	-79	-90	-51	-27	-36	-50
EBITDA-CapEx	-10	-12	-39	-79	-90	-51	-27	-36	-51
Operating Income (Loss)	-10	-12	-39	-79	-90	-51	-27	-36	-50

Liquidity (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	4.17	49.22	11.23	7.87	7.51	29.38	7.84	5.6	0.41
Current Ratio	4.28	49.82	11.93	8.11	7.85	30.55	8.09	6.05	0.53
Quick Ratio	4.17	49.22	11.23	7.87	7.59	29.71	7.95	5.72	0.49
CFO/Avg Current Liab	- -	-7.26	-6.43	-3.93	-4.03	-5.09	-2.89	-3.79	-1.64
Common Equity/Total Assets	-263.62	-45.04	-56.11	-77.39	-177.57	-277.38	-190.35	-328.82	-492.28
Long-Term Debt/Equity (%)	- -	- -	- -	0.12	0.35	- -	16.16	48.81	- -
Long-Term Debt/Capital (%)	-54.43	- -	- -	-0.14	-0.18	- -	-4.5	-4.07	-0.07
Long-Term Debt/Total Assets (%)	92.91	- -	- -	0.11	0.32	- -	8.19	12.85	0.35
Total Debt/Equity (%)	-35.36	- -	- -	0.26	0.98	0.45	16.24	49.13	-51.72
Total Debt/Capital (%)	-54.43	- -	- -	-0.31	-0.49	-0.16	-4.52	-4.1	-4.18
Total Debt/Total Assets (%)	92.91	- -	- -	0.24	0.87	0.44	8.23	12.94	19.75
CFO/Total Liabilities	-35.1	-11.08	-374.24	-295.38	-429.8	-1,327.65	-22.09	-37.83	-32.05
CFO/CapEx	-127.62	-55.17	-605.04	-977.27	-349.62	-331.11	-114.32	-124.14	-117.68
Altman's Z-Score	-7.23	-0.01	71.32	26.57	11.52	-0.87	-4.98	-10.49	-31.72

Working Capital (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	1,070	811	375	21	39	81	168
- Cash & Cash Equivalents	7	25	51	67	70	45	21	6	6
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	7	- -	- -	- -	1	- -	14	15	18
Enterprise Value	- -	-72	970	677	269	-68	-22	55	169
Total Capital	-13	-33	-70	-146	-235	-288	-306	-362	-442
Total Debt/Capital (%)	-54.43	- -	- -	-0.31	-0.49	-0.16	-4.52	-4.1	-4.18
Total Debt / EV	-41.69	- -	- -	- -	- -	-0.01	-0.62	0.27	0.11
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	1,070	811	375	21	39	81	168
Diluted Enterprise Value	- -	-25	1,019	744	306	-23	32	89	180
EV per Share	- -	- -	10,180.21	4,641.73	1,813.05	100.61	193.55	253.93	672.87
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	-10	-12	-39	-79	-90	-51	-27	-36	-50
TTM Operating Income	-10	-12	-39	-79	-90	-51	-27	-36	-50
TTM Cash Flow to Firm	-8	-11	-33	-51	-63	-44	-18	-32	-41
TTM Free Cash Flow to Firm	-8	-11	-33	-51	-63	-44	-18	-32	-41

Multiples (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-32.21	-15.97	-5.98	-0.49	-2.16	-2.56	-4.09
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	-72	970	677	269	-68	-22	55	169
Low Price	- -	- -	3,870	5,332.2	2,142	108	127.4	102.4	144
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-15.64	-17.54	-15.57	-2.11	-1.44	-0.83	-1.03
Price/Earnings High	- -	- -	-37.6	-28.03	-40.3	-8.88	-2.29	-1.87	-2.71
Price/Earnings Low	- -	- -	-9.97	-10.12	-3.54	-0.35	-0.76	-0.39	-0.43
Price/Book Value	- -	- -	-15.34	-5.53	-1.59	-0.07	-0.12	-0.21	-0.36
Price/Book Value Average	- -	- -	-8.29	-9.2	-5.92	-0.38	-0.14	-0.13	-0.19
Price/Book Value High	- -	- -	-19.93	-14.69	-15.32	-1.59	-0.22	-0.28	-0.5
Price/Book Value Low	- -	- -	-5.29	-5.31	-1.35	-0.06	-0.07	-0.06	-0.08
Price/Tangible Book Value	- -	- -	9.27	4.71	3.16	0.23	10.32	-2.71	-1.62
Price/Tangible Book Value Average	- -	- -	5.01	7.83	11.81	1.15	11.9	-1.58	-0.83
Price/Tangible Book Value High	- -	- -	12.04	12.51	30.57	4.85	18.98	-3.55	-2.2
Price/Tangible Book Value Low	- -	- -	3.19	4.52	2.68	0.19	6.26	-0.74	-0.35
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	-32.16	-15.95	-5.96	-0.48	-2.14	-2.54	-4.05
Price/Cash Flow Average	- -	- -	-17.38	-26.53	-22.26	-2.47	-2.46	-1.48	-2.08
Price/Cash Flow High	- -	- -	-41.78	-42.39	-57.6	-10.42	-3.93	-3.32	-5.5
Price/Cash Flow Low	- -	- -	-11.08	-15.31	-5.06	-0.41	-1.3	-0.69	-0.87
Price/Free Cash Flow Average	- -	- -	-17.4	-26.56	-22.32	-2.48	-2.49	-1.49	-2.1
Price/Free Cash Flow High	- -	- -	-41.85	-42.44	-57.77	-10.45	-3.96	-3.35	-5.55
Price/Free Cash Flow Low	- -	- -	-11.1	-15.32	-5.07	-0.41	-1.31	-0.7	-0.88
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	0.02	2.06	-13.52	-16.32	-14.81	-1.27	-1.42	-1.55	-1.97
EV/EBITDA High	0.02	2.06	-34.35	-26.58	-39.53	-8.14	-2.42	-3.18	-4.78
EV/EBITDA Low	0.02	2.06	-8.15	-9.06	-2.78	0.51	-0.63	-0.85	-0.97
EV/EBIT Average	0.02	2.05	-13.45	-16.25	-14.75	-1.26	-1.4	-1.54	-1.96
EV/EBIT High	0.02	2.05	-34.19	-26.47	-39.38	-8.1	-2.39	-3.17	-4.77
EV/EBIT Low	0.02	2.05	-8.11	-9.02	-2.76	0.51	-0.62	-0.85	-0.97
Last Price	- -	- -	11,228	5,556	2,524	127.4	210	374	670
High Price	- -	- -	14,588	14,768	24,396	2,740	386	490	910
Enterprise Value Average	- -	-25	527	1,282	1,332	65	38	56	99
Enterprise Value High	- -	-25	1,339	2,088	3,556	415	65	115	241
Enterprise Value Low	- -	-25	318	711	250	-26	17	31	49

Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	-95.82	-111.99	-408.99	-538.53	-605.51	-304.43	-144.05	-166.35	-200.76
Operating Income per Share	-96.24	-112.47	-410.96	-540.8	-607.83	-305.64	-145.78	-167.21	-201.33
Basic EPS, GAAP	-113.54	-115.78	-388	-526.79	-605.32	-308.45	-168.57	-262.71	-335.27
Basic EPS from Cont Ops	-113.54	-115.78	-388	-526.79	-605.32	-308.45	-168.57	-262.71	-335.27
Diluted EPS, GAAP	-113.54	-115.78	-388	-526.79	-605.32	-308.45	-168.57	-262.71	-335.27
Diluted EPS from Cont Ops	-113.54	-115.78	-388	-526.79	-605.32	-308.45	-168.57	-262.71	-335.27
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-91.2	-108.53	-349.15	-348.35	-423.52	-262.94	-98.25	-147.49	-165.38
Free Cash Flow per Basic Share	-91.91	-110.5	-349.73	-348.71	-424.73	-263.74	-99.11	-148.68	-166.79
Cash & Equivalents per Share	68.15	665.55	1,047.79	917.32	718.76	538.45	403.14	188.54	70.87
Book Value per Share	-188.82	-304.6	-732.12	-1,005.1	-1,592.07	-1,720.92	-1,716.58	-1,740.22	-1,838.03
Tangible Book Value per Share	-188.2	-302.78	1,211.62	1,180.84	798.06	565.39	20.34	-138.22	-413.33

Quince Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)